Undecimal Bio has launched with $18 million (about €16 million) in seed funding to develop delivery molecules that carry gene ...

Swedish biotech Elicera Therapeutics reported complete metabolic responses in eight of 12 patients treated with its ...

Finnish biotech Desentum has raised €28 million in an oversubscribed equity round to advance three allergy immunotherapy ...

Over the past few years, Belgium’s argenx has become a biotech force to be reckoned with, driven by the success of its ...

Perfusion is here, and it is rewriting the rules of biologics and biosimilar manufacturing. What was once experimental has become industrial reality: scalable, robust, regulatorily accepted, and ...

For CDMOs, flexible upstream platforms can help streamline process ­development while maintaining reproducibility and ...

Italy's Newron Pharmaceuticals has disclosed that the FDA kept U.S. enrollment in a Phase 3 trial of its schizophrenia drug evenamide on hold, citing five deaths across all the drug's clinical studies ...

Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us ...

Swiss biotech ADC Therapeutics has secured an $86.6 million (€77.5 million) financing agreement alongside debt and royalty ...

Zealand Pharma shares fell about 4% in Thursday trading after new Phase 2 results for its Roche-partnered obesity drug petrelintide showed encouraging weight loss but a modest improvement in blood ...

Roche has partnered with China’s Defand Therapeutics to discover molecular glue degraders for cancer and immune diseases, in a research and licensing agreement reportedly worth close to $1 billion ...

Paris-based Rivercell has raised $25 million (about €22 million) in seed funding to generate experimental data and build AI ...